IBA-11
IBA-11 is a selective CRBN-dependented CK1α molecular glue degrader. IBA-11 binds to the canonical tri-tryptophan pocket of CRBN, forming a ternary complex with CK1α to mediate its degradation. IBA-11 induces CRBN-dependent ubiquitin-proteasome system-mediated degradation of CK1α. IBA-11 exhibits cytotoxicity against cancer cells. IBA-11 demonstrates in vitro metabolic stability in rat liver microsomes and minimal hERG inhibition. IBA-11 can be used for the research of cancer, such as acute myeloid leukemia.
For research use only. We do not sell to patients.
- Formula: C22H17F2N5O3
- Molecular Weight:437.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CK1α |
Cereblon |
In Vitro
IBA-11 binds to CRBN with an IC50 of 2285 nM in a cell-free TR-FRET assay[1].
IBA-11 potently inhibits the viability of MV-4-11 cells with an IC50 of 82.11 nM, and shows minimal activity in MM.1S and Mino cells[1].
IBA-11 (0.1-2.5 nM; 8 h) induces dose-dependent degradation of CK1α, but not IKZF1/2/3 or GSPT1, in MV-4-11 and Mino cells[1].
IBA-11 (500 nM; 2-16 h) induces rapid, near-complete degradation of CK1α in Mino cells within 2 h[1].
IBA-11 (500 nM; 3 h) induced CK1α degradation in Mino cells is dependent on the CRBN-mediated ubiquitin-proteasome system, as confirmed by rescue with MLN4924 (HY-70062), PS341 (HY-10227), and MG132 (HY-13259) [1].
IBA-11 (0.2-2 μM) induced CK1α degradation is strictly CRBN-dependent, as degradation is abolished in CRBN-knockout HEK293T cells[1].
IBA-11 has favorable in vitro metabolic stability in rat liver microsomes and a low risk of cardiac toxicity, as indicated by minimal hERG inhibition (IC50 >40 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV-4-11, Mino
-
Concentration:0.1, 0.5, 2.5 nM
-
Incubation Time:8 h
-
Result:Induced dose-dependent degradation of CK1α in both MV-4-11 and Mino cells.
Left IKZF1/2/3 and GSPT1 largely unaffected across all tested concentrations.
-
Cell Line:Mino
-
Concentration:500 nM
-
Incubation Time:2, 4, 8, 16 h
-
Result:Induced near-complete depletion of CK1α within 2 h of treatment.
Induced time-dependent degradation.
Chemical Information
-
Molecular Weight 437.40
-
Formula C22H17F2N5O3
-
SMILES
O=C1CCC(N2NC(C=C(C3=CN(C)C(C4=CC(F)=CC(F)=C4)=N3)C=C5)=C5C2=O)C(N1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)